HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
16 hedge funds and large institutions have $5.43M invested in Hepion Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
16
Holding in Top 10
–
Calls
$46K
Puts
–
Top Buyers
| 1 | +$1.63M | |
| 2 | +$199K | |
| 3 | +$72.6K | |
| 4 |
BlackRock
New York
|
+$58.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$22K |
Top Sellers
| 1 | -$122K | |
| 2 | -$103K | |
| 3 | -$68.9K | |
| 4 |
ML
McAdam LLC
Philadelphia,
Pennsylvania
|
-$48.3K |
| 5 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$47.5K |